{"id":"https://openalex.org/W2222256254","doi":null,"title":"ABCB1 C3435T genetic Polymorphism and response to Glibenclamide therapy in patients with type 2 diabetes mellitus","display_name":"ABCB1 C3435T genetic Polymorphism and response to Glibenclamide therapy in patients with type 2 diabetes mellitus","alternate_titles":[],"publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W2222256254","mag":"2222256254"},"language":"en","primary_location":{"id":"mag:2222256254","doi":null,"is_oa":false,"landing_page_url":"http://www.ijpcs.net/sites/default/files/10.5530ijpcs.4.2.1.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210218410","display_name":"International Journal of Pharmacology and Clinical Sciences","issn_l":"2278-0068","issn":["2278-0068","2676-2692"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharmacology and Clinical Sciences","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2222256254"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052749634","display_name":"A Surendiran","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Surendiran","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019900118","display_name":"Pradhan Sc","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pradhan Sc","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006736808","display_name":"Subrahmanyam Dks","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Subrahmanyam Dks","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100840666","display_name":"Aparna Agrawal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aparna Agrawal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037286368","display_name":"Gurusamy Umamaheswaran","orcid":"https://orcid.org/0000-0002-8709-9159","observed_orcids":["https://orcid.org/0000-0002-8709-9159"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gurusamy Umamaheswaran","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8709-9159","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019641207","display_name":"Seena Cheppala Rajan","orcid":"https://orcid.org/0000-0003-0522-4276","observed_orcids":["https://orcid.org/0000-0003-0522-4276"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seena Cheppala Rajan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0522-4276","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5103072768","display_name":"C Adithan","orcid":"https://orcid.org/0000-0002-6246-2601","observed_orcids":["https://orcid.org/0000-0002-6246-2601"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Adithan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6246-2601","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"4","issue":"2","first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10261","display_name":"Genetic Associations and Epidemiology","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abcb1-c3435t-polymorphism","display_name":"ABCB1 C3435T polymorphism","score":0.9520000219345093},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.8740000128746033},{"id":"https://openalex.org/keywords/glibenclamide","display_name":"glibenclamide","score":0.9929999709129333},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.796999990940094},{"id":"https://openalex.org/keywords/drug-response","display_name":"drug response","score":0.6380000114440918},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.8230000138282776},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9649999737739563},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7400000095367432},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.7960000038146973},{"id":"https://openalex.org/keywords/south-indian-patients","display_name":"South Indian patients","score":0.8799999952316284}],"concepts":[{"id":"https://openalex.org/C2779768347","wikidata":"https://www.wikidata.org/wiki/Q420626","display_name":"Glibenclamide","level":3,"score":0.9685438275337219},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.7160210609436035},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7109007835388184},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7012898921966553},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6622427105903625},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.6490278840065002},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.5243668556213379},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.48508062958717346},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4611871838569641},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.41133439540863037},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3016818165779114},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16554605960845947},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.12865164875984192},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09723794460296631}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2222256254","doi":null,"is_oa":false,"landing_page_url":"http://www.ijpcs.net/sites/default/files/10.5530ijpcs.4.2.1.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210218410","display_name":"International Journal of Pharmacology and Clinical Sciences","issn_l":"2278-0068","issn":["2278-0068","2676-2692"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharmacology and Clinical Sciences","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W94170870","https://openalex.org/W1968062717","https://openalex.org/W1975315797","https://openalex.org/W2006503069","https://openalex.org/W2028899000","https://openalex.org/W2059743234","https://openalex.org/W2072641731","https://openalex.org/W2074084823","https://openalex.org/W2092332796","https://openalex.org/W2095174320","https://openalex.org/W2141163408","https://openalex.org/W2148183823","https://openalex.org/W2301905714","https://openalex.org/W2345903479"],"related_works":["https://openalex.org/W7147619954","https://openalex.org/W1989031570","https://openalex.org/W7158145700","https://openalex.org/W2023711323","https://openalex.org/W4365998447","https://openalex.org/W2790093120","https://openalex.org/W4210684237","https://openalex.org/W2297773355","https://openalex.org/W2803438014","https://openalex.org/W2498758916"],"abstract_inverted_index":{"Background:":[0],"Glibenclamide":[1],"is":[2,11],"a":[3,64,72],"substrate":[4],"and":[5,36,41,80,104,110,122,146,157,171,178,192,221],"an":[6],"inhibitor":[7],"of":[8,22,31,53,83,148,167,173,189,194,224],"P-glycoprotein":[9],"which":[10],"coded":[12],"by":[13],"the":[14,20,28,105,151,198,213,222],"gene":[15,25],"ABCB1.":[16],"Objective:":[17],"To":[18],"study":[19,44],"influence":[21,211],"ABCB1":[23,76,154,176,202],"C3435T":[24,77,203],"polymorphism":[26,79,205],"on":[27,59,212],"therapeutic":[29,214],"effect":[30],"glibenclamide,":[32,190,217],"its":[33],"plasma":[34,81,187,218],"levels":[35,82,220],"hypoglycemic":[37,128],"adverse":[38,195,225],"effects.":[39],"Materials":[40],"Methods:":[42],"The":[43,87,118],"was":[45,112,160],"done":[46],"in":[47,141,186,227],"Type":[48],"2":[49,169,233],"diabetes":[50,170,234],"mellitus":[51],"patients":[52,230],"South":[54,228],"India":[55],"(n=80)":[56],"who":[57],"were":[58,85,89,98,130,137,181],"treatment":[60,149],"with":[61,69,231],"glibenclamide":[62,84,219],"as":[63,125],"single":[65],"agent":[66],"or":[67],"along":[68],"metformin.":[70],"From":[71],"venous":[73],"blood":[74],"sample,":[75],"genetic":[78,204],"determined.":[86],"parameters":[88,123],"compared":[90,131],"between":[91,107,120,150,164,197],"genotype":[92,111,152,199],"groups.":[93,200],"Patient":[94],"characteristics":[95],"across":[96],"genotypes":[97,121,175],"analyzed":[99],"using":[100,114,132],"one":[101],"way":[102],"ANOVA":[103],"association":[106,119,163],"glycemic":[108,165],"status":[109,166],"studied":[113],"Chi":[115],"Square":[116],"test.":[117],"such":[124],"C/D":[126],"values,":[127],"episodes":[129],"Kruskal":[133],"Wallis":[134],"Test.":[135],"Results:There":[136],"no":[138,161,182],"significant":[139,162,184,210],"differences":[140,185],"age,":[142],"body":[143],"mass":[144],"index":[145],"duration":[147],"groups":[153],"CC,":[155],"CT":[156,177],"TT.":[158,179],"There":[159,180],"type":[168,232],"presence":[172],"variant":[174],"statistically":[183],"concentration":[188],"number":[191],"severity":[193],"effects":[196],"Conclusion:":[201],"did":[206],"not":[207],"produce":[208],"any":[209],"response":[215],"to":[216],"occurrence":[223],"events":[226],"Indian":[229],"mellitus.":[235]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2222256254","counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-06-24T00:00:00"}
